It appears that the IL-2-dependent pathway (the pathway involving the cytokine and the corresponding receptor) does not serve as the key mechanism underlying the autocrine activation of T cell proliferation and the in vitro survival of the tumor clone. The gene discussed is IL2; the disease is neoplasm.